Skip to main content

Advertisement

Table 2 Levels of sCD138 and time frame of sample collection in patients with HFRS

From: Study on expression of plasma sCD138 in patients with hemorrhagic fever with renal syndrome

  Mild group
(n = 32)
Moderate group
(n = 50)
Severe group
(n = 43)
Critical group
(n = 51)
Control group (n = 35)
sCD138, ng/mL
a Acute stage 3.45 ± 2.32 5.29 ± 3.64 4.73 ± 3.83 5.22 ± 3.19 0.819 (0.260)
b Convalescent stage 2.71 ± 2.45* 2.78 ± 1.39* 2.54 ± 1.68* 2.56 ± 2.58* 0.819 (0.260)
Length of time (days)
c Acute stage 7 (4) 7 (3) 7 (3) 7 (4)
d Convalescent stage 11.5 (4) 13 (3) 17 (10) 22 (10)
  1. aKruskal-Wallis H test: χ2 = 89.367, P<0.001. b Kruskal-Wallis H test: χ2 = 75.894, P<0.001
  2. cKruskal-Wallis H test: χ2 = 5.612, P = 0.312. d Kruskal-Wallis H test: χ2 = 45.344, P<0.001
  3. *Comparison of the levels of sCD138 between the acute and convalescent stage: mild group, t = 0.873 P = 0.387; moderate group, t = 4.253 P<0.001; severe group, t = 3.253 P = 0.002; critical group, t = 3.748 P<0.001